UY34759A - USO DE 18-METIL-15B(Beta),16B(Beta)-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, EN LA TERAPIA DE LA MENORRAGIA, ASI COMO SISTEMAS INTRAUTERINOS QUE CONTIENEN 18-METIL-15B(Beta),16B(Beta)-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS PARA LA TERAPIA DE TRASTORNOS DE HEMORRAGIAS UTERINAS. - Google Patents
USO DE 18-METIL-15B(Beta),16B(Beta)-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, EN LA TERAPIA DE LA MENORRAGIA, ASI COMO SISTEMAS INTRAUTERINOS QUE CONTIENEN 18-METIL-15B(Beta),16B(Beta)-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS PARA LA TERAPIA DE TRASTORNOS DE HEMORRAGIAS UTERINAS.Info
- Publication number
- UY34759A UY34759A UY34759A UY34759A UY34759A UY 34759 A UY34759 A UY 34759A UY 34759 A UY34759 A UY 34759A UY 34759 A UY34759 A UY 34759A UY 34759 A UY34759 A UY 34759A
- Authority
- UY
- Uruguay
- Prior art keywords
- beta
- metilen
- espirox
- onas
- therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención describe el uso intrauterino de 18?metil?15ß,16ß?metilen?19?nor?20?espirox?4?en?3?onas de la fórmula general (1) en donde R6 y R7 representan hidrógeno o un grupo metileno, en la terapia de la menorragia, en general de sangrados uterino, así como un sistema intrauterino para la aplicación mencionada que contiene un compuesto de la fórmula 1.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102012206653 | 2012-04-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY34759A true UY34759A (es) | 2013-11-29 |
Family
ID=48141995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY34759A UY34759A (es) | 2012-04-23 | 2013-04-23 | USO DE 18-METIL-15B(Beta),16B(Beta)-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, EN LA TERAPIA DE LA MENORRAGIA, ASI COMO SISTEMAS INTRAUTERINOS QUE CONTIENEN 18-METIL-15B(Beta),16B(Beta)-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS PARA LA TERAPIA DE TRASTORNOS DE HEMORRAGIAS UTERINAS. |
Country Status (28)
Country | Link |
---|---|
US (1) | US20150119372A1 (es) |
EP (1) | EP2841073A1 (es) |
JP (1) | JP2015514789A (es) |
KR (1) | KR20150005548A (es) |
CN (1) | CN104379149A (es) |
AR (1) | AR090800A1 (es) |
AU (1) | AU2013251842A1 (es) |
BR (1) | BR112014026086A2 (es) |
CA (1) | CA2871001A1 (es) |
CL (1) | CL2014002857A1 (es) |
CO (1) | CO7111253A2 (es) |
CR (1) | CR20140489A (es) |
CU (1) | CU20140120A7 (es) |
DO (1) | DOP2014000240A (es) |
EA (1) | EA201491917A1 (es) |
EC (1) | ECSP14024263A (es) |
GT (1) | GT201400225A (es) |
HK (1) | HK1206271A1 (es) |
IL (1) | IL235096A0 (es) |
MA (1) | MA37443A1 (es) |
MX (1) | MX2014012848A (es) |
PE (1) | PE20142437A1 (es) |
PH (1) | PH12014502371A1 (es) |
SG (1) | SG11201406583QA (es) |
TN (1) | TN2014000445A1 (es) |
TW (1) | TW201345530A (es) |
UY (1) | UY34759A (es) |
WO (1) | WO2013160200A1 (es) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI90627C (fi) | 1992-07-31 | 1994-03-10 | Leiras Oy | Laitteisto lääkeainesauvan varustamiseksi vaipalla |
PH30867A (en) | 1992-07-31 | 1997-12-09 | Leiras Oy | Method and equipment for installing a medicine capsule on a support. |
FI107339B (fi) | 1998-06-30 | 2001-07-13 | Leiras Oy | Lääkeaineiden läpäisynopeutta säätävä kalvo tai matriisi |
US6056976A (en) | 1998-11-12 | 2000-05-02 | Leiras Oy | Elastomer, its preparation and use |
DE102006030416A1 (de) | 2006-06-29 | 2008-01-03 | Bayer Schering Pharma Ag | 18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate |
-
2013
- 2013-04-19 WO PCT/EP2013/058152 patent/WO2013160200A1/de active Application Filing
- 2013-04-19 EA EA201491917A patent/EA201491917A1/ru unknown
- 2013-04-19 MX MX2014012848A patent/MX2014012848A/es unknown
- 2013-04-19 AU AU2013251842A patent/AU2013251842A1/en not_active Abandoned
- 2013-04-19 PE PE2014001785A patent/PE20142437A1/es not_active Application Discontinuation
- 2013-04-19 CA CA 2871001 patent/CA2871001A1/en not_active Abandoned
- 2013-04-19 SG SG11201406583QA patent/SG11201406583QA/en unknown
- 2013-04-19 BR BR112014026086A patent/BR112014026086A2/pt not_active IP Right Cessation
- 2013-04-19 KR KR20147029290A patent/KR20150005548A/ko not_active Application Discontinuation
- 2013-04-19 EP EP13717280.5A patent/EP2841073A1/de not_active Withdrawn
- 2013-04-19 MA MA37443A patent/MA37443A1/fr unknown
- 2013-04-19 JP JP2015507478A patent/JP2015514789A/ja active Pending
- 2013-04-19 CN CN201380021631.5A patent/CN104379149A/zh active Pending
- 2013-04-19 US US14/396,742 patent/US20150119372A1/en not_active Abandoned
- 2013-04-23 UY UY34759A patent/UY34759A/es not_active Application Discontinuation
- 2013-04-23 TW TW102114450A patent/TW201345530A/zh unknown
- 2013-04-23 AR ARP130101342 patent/AR090800A1/es unknown
-
2014
- 2014-10-19 IL IL235096A patent/IL235096A0/en unknown
- 2014-10-22 TN TN2014000445A patent/TN2014000445A1/fr unknown
- 2014-10-22 CU CU2014000120A patent/CU20140120A7/es unknown
- 2014-10-22 PH PH12014502371A patent/PH12014502371A1/en unknown
- 2014-10-23 CR CR20140489A patent/CR20140489A/es unknown
- 2014-10-23 GT GT201400225A patent/GT201400225A/es unknown
- 2014-10-23 CL CL2014002857A patent/CL2014002857A1/es unknown
- 2014-10-23 CO CO14235151A patent/CO7111253A2/es unknown
- 2014-10-23 DO DO2014000240A patent/DOP2014000240A/es unknown
- 2014-10-24 EC ECIEPI201424263A patent/ECSP14024263A/es unknown
-
2015
- 2015-07-22 HK HK15106972.2A patent/HK1206271A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BR112014026086A2 (pt) | 2017-07-18 |
TN2014000445A1 (en) | 2016-03-30 |
SG11201406583QA (en) | 2014-11-27 |
EA201491917A1 (ru) | 2015-04-30 |
PH12014502371A1 (en) | 2015-01-12 |
CA2871001A1 (en) | 2013-10-31 |
CR20140489A (es) | 2014-12-24 |
TW201345530A (zh) | 2013-11-16 |
MX2014012848A (es) | 2015-02-05 |
AR090800A1 (es) | 2014-12-10 |
ECSP14024263A (es) | 2015-12-31 |
CO7111253A2 (es) | 2014-11-10 |
PE20142437A1 (es) | 2015-01-31 |
DOP2014000240A (es) | 2015-02-15 |
CL2014002857A1 (es) | 2015-02-06 |
HK1206271A1 (en) | 2016-01-08 |
JP2015514789A (ja) | 2015-05-21 |
MA37443A1 (fr) | 2016-05-31 |
GT201400225A (es) | 2016-01-22 |
AU2013251842A1 (en) | 2014-11-06 |
US20150119372A1 (en) | 2015-04-30 |
CN104379149A (zh) | 2015-02-25 |
CU20140120A7 (es) | 2015-02-26 |
WO2013160200A1 (de) | 2013-10-31 |
KR20150005548A (ko) | 2015-01-14 |
EP2841073A1 (de) | 2015-03-04 |
IL235096A0 (en) | 2014-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2018005369A2 (es) | Inhibidores triazol de acc y usos de los mismos | |
UY35500A (es) | Indazoles sustituidos con heteroarilo | |
UY34585A (es) | Compuestos b-lactámicos sustituidos con amidina, su preparación y uso | |
CR20160033A (es) | Inhibidores de autotaxina que comprenden un nucleo ciclico de anillo heteroaromático-bencil-amida | |
UY34566A (es) | 1,4?dihidropirimidinas 4,4?disustituidas y su uso como medicamentos para el tratamiento de la hepatitis b | |
UY34632A (es) | Compuestos de oxazolidin- 2- ona y usos de los mismos | |
UY34669A (es) | COMPUESTOS EN BASE A IMIDAZO[1,2-b]PIRIDAZINA, COMPOSICIONES QUE LOS COMPRENDEN Y MÉTODOS PARA SU USO. | |
UY34765A (es) | Compuestos novedosos. | |
CL2016001266A1 (es) | Nuevo octahidro-ciclobuta[1,2-c;3,4-c']dipirrol-2-ilo. | |
UY34467A (es) | Procedimiento para la preparación de 5-fluoro-1h-pirazolopiridinas sustituidas | |
UY34797A (es) | Uracilos sustituidos bicíclicamente y uso de los mismos | |
UY34767A (es) | Inhibidores cíclicos del enlace éter de dgat1 | |
UY34725A (es) | Nuevos derivados de tienopirimidina, procesos para su preparación y sus usos terapéuticos. | |
UY34356A (es) | Derivados de estra-1,3,5(10),16-tetraen-3-carboxamida, procedimientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparación de medicamentos | |
BR112015030308A2 (pt) | antagonistas de progesterona de imidazolila | |
UY34612A (es) | ?procedimiento para la preparación de derivados de isoxazolina azetidina quirales como agentes antiparasitarios?. | |
UY35332A (es) | Derivados de pirrolotriazina como inhibidores de pi3k | |
CO7160067A2 (es) | Formulaciones de agonistas del receptor de somatostatina | |
AR102980A1 (es) | Un proceso para la fabricación de idalopirdina | |
MX2016000487A (es) | Piridina-2-carboxamidas como nematicidas. | |
UY34734A (es) | Un antagonista del receptor h3 para uso en el tratamiento de la enfermedad de alzheimer. | |
UY34759A (es) | USO DE 18-METIL-15B(Beta),16B(Beta)-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, EN LA TERAPIA DE LA MENORRAGIA, ASI COMO SISTEMAS INTRAUTERINOS QUE CONTIENEN 18-METIL-15B(Beta),16B(Beta)-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS PARA LA TERAPIA DE TRASTORNOS DE HEMORRAGIAS UTERINAS. | |
UY34758A (es) | USO INTRAUTERINO DE 18-METIL-15B(Beta),16B(Beta)-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, SISTEMAS INTRAUTERINOS QUE CONTIENEN 18-METIL-15B(Beta),16B(Beta)-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, ASÍ COMO SU USO EN LA ANTICONCEPCIÓN Y TERAPIA GINECOLÓGICA. | |
CR20140051A (es) | Compuestos de tiazol y oxazol de bencen-sulfonamida | |
UY34592A (es) | Derivados de óxido de benciloxipirimidina,insecticidas agrohortícolas que comprenden dichos derivados y método de uso de los mismos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20210715 |